Resona Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.6M Sell
40,551
-2,802
-6% -$550K 0.04% 365
2026
Q1
$8.5M Sell
43,353
-144
-0.3% -$28K 0.04% 364
2025
Q4
$7.56M Sell
43,497
-646
-1% -$118K 0.04% 398
2025
Q3
$8.4M Sell
44,143
-1,458
-3% -$259K 0.04% 371
2025
Q2
$8.18M Buy
45,601
+1,861
+4% +$323K 0.04% 383
2025
Q1
$7.39M Buy
43,740
+2,545
+6% +$418K 0.04% 368
2024
Q4
$6.22M Sell
41,195
-1,290
-3% -$201K 0.04% 409
2024
Q3
$6.59M Sell
42,485
-1,039
-2% -$155K 0.04% 398
2024
Q2
$5.96M Sell
43,524
-1,472
-3% -$202K 0.04% 405
2024
Q1
$5.99M Buy
+44,996
New +$5.84M 0.04% 429

Other funds holding DGX

Resona Asset Management's DGX Position: Q2 2026 in Review

Resona Asset Management reduced its Quest Diagnostics (DGX) stake by 6.5% in Q2 2026, selling an estimated $550K and leaving 40,551 shares worth $8.6M. The position accounts for 0.04% of the portfolio, ranked #365.

Resona Asset Management first reported a position in DGX in Q1 2024 and has held it in 10 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Resona Asset Management held 40,551 shares of Quest Diagnostics worth $8.6M as of Q2 2026.
  • Resona Asset Management sold 2,802 Quest Diagnostics shares in Q2 2026, an estimated $550K.
  • Quest Diagnostics made up 0.04% of Resona Asset Management's portfolio in Q2 2026, its #365 holding.
  • Resona Asset Management first reported a position in Quest Diagnostics in Q1 2024 and has held it in 10 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.